輸入代號或公司名稱後按 Enter
4743

合一

+0.05 (+0.12%)最後更新 2026-09-15
台灣 · 上櫃 · 生技醫療業
43.50720成交張數334.62本益比2.04股價淨值比0.00%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025129年增 +9.5%
毛利率202530.9%最新一期
營業利益率2025-621.9%最新一期
每股盈餘2025-2.18
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計50.0%47.2%54.1%126.2%26.2%31.5%20.8%62.5%46.5%69.1%
營業毛利(毛損)50.0%52.8%45.9%-26.2%73.8%68.5%79.2%37.5%53.5%30.9%
未實現銷貨(損)益2.2%0.0%17.0%0.0%0.5%3.5%
已實現銷貨(損)益0.5%
營業毛利(毛損)淨額50.0%52.8%43.6%-26.2%56.9%68.5%79.2%37.5%52.9%27.8%
推銷費用48.0%199.2%2.5%5.6%1.1%34.8%4.4%63.0%52.2%50.1%
管理費用887.1%2700.9%241.3%510.6%257.4%143.4%11.3%140.5%137.4%130.4%
研究發展費用1099.0%2529.3%500.8%1771.0%1416.4%1225.5%86.2%1097.6%784.3%469.2%
營業費用合計2034.1%5429.4%744.7%2287.2%1674.9%1403.8%101.9%1301.2%973.9%649.7%
營業利益(損失)-1984.1%-5376.6%-701.0%-2313.4%-1618.0%-1335.3%-22.7%-1263.6%-921.0%-621.9%
利息收入30.8%45.5%4.8%325.8%242.7%169.8%
其他收入129.2%332.9%55.2%74.1%24.3%28.4%1.2%15.9%10.4%12.5%
其他利益及損失淨額1701.9%-257.6%-538.3%190.9%-193.4%240.5%51.0%-14.7%64.8%-174.8%
財務成本淨額0.1%0.2%0.0%46.4%12.4%7.4%0.4%6.5%8.1%6.9%
採用權益法認列之關聯企業及合資損益之份額淨額-96.8%-725.7%-114.8%-326.4%1168.0%426.2%8.4%-574.7%-363.7%-196.6%
營業外收入及支出合計1734.1%-650.6%-598.0%-107.8%1017.3%733.2%65.0%-254.3%-54.0%-196.0%
稅前淨利(淨損)-250.0%-6027.2%-1299.0%-2421.2%-600.7%-602.1%42.4%-1517.9%-975.0%-817.9%
所得稅費用(利益)合計0.0%4.2%25.6%9.4%6.1%2.8%2.7%
繼續營業單位本期淨利(淨損)-250.0%-6027.2%-1299.0%-2421.2%-604.9%-627.7%33.0%-1524.0%-977.7%-820.6%
本期淨利(淨損)-250.0%-6027.2%-1299.0%-2421.2%-604.9%-627.7%33.0%-1524.0%-977.7%-820.6%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-1431.7%199.7%3510.1%402.1%-0.7%76.2%-427.5%-534.6%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目13.2%1008.5%159.2%-4.4%-53.9%-168.8%-214.9%
不重分類至損益之項目:212.9%4518.6%561.3%-5.1%22.3%-596.3%-749.6%
國外營運機構財務報表換算之兌換差額-313.0%-249.8%-13.4%-155.1%0.0%-0.0%0.9%18.7%17.3%-12.8%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-50.3%43.1%-10.2%1.2%-16.7%21.9%2.2%
與可能重分類之項目相關之所得稅-287.4%-42.5%-4.0%-28.0%5.6%-1.7%0.2%-0.5%4.7%-3.4%
後續可能重分類至損益之項目:-177.4%37.5%-8.6%1.8%2.5%34.5%-7.2%
其他綜合損益(淨額)-4195.8%-1291.7%-1441.1%35.5%4556.2%552.7%-3.3%24.7%-561.8%-756.7%
本期綜合損益總額-4445.8%-7318.9%-2740.1%-2385.7%3951.2%-75.1%29.7%-1499.2%-1539.5%-1577.3%
母公司業主(淨利∕損)-6008.7%-1248.6%-2391.1%-581.4%-613.2%33.8%-1512.8%-988.0%-809.1%
非控制權益(淨利∕損)-18.4%-50.4%-30.1%-23.5%-14.5%-0.8%-11.2%10.3%-11.4%
母公司業主(綜合損益)-7300.4%-2684.6%-2357.8%3964.9%-60.6%29.9%-1498.8%-1559.4%-1568.8%
非控制權益(綜合損益)-18.4%-55.5%-28.0%-13.7%-14.5%-0.2%-0.5%19.9%-8.5%
基本每股盈餘-1.2%-30.9%-6.4%-9.5%-1.6%-1.6%0.1%-3.4%-2.1%-1.7%
稀釋每股盈餘-1.2%-30.9%-6.4%-9.5%-1.6%-1.6%0.1%-3.4%-2.1%-1.7%
繼續營業單位淨利(淨損)-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%0.0%-0.0%
備供出售金融資產未實現評價損益-4170.2%-1084.3%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。